rs10204525 binding to miR-4717-3p modulates PD-1 expression and predicts the development of immune-related adverse events in patients with advanced cancer treated with anti-PD-1/PD-L1 therapy

rs10204525 与 miR-4717-3p 的结合调节 PD-1 表达，并预测接受抗 PD-1/PD-L1 治疗的晚期癌症患者发生免疫相关不良事件的风险。